Catalyst Wire Dossier Catalyst Wire Dossier

CT-P6

trastuzumab biosimilar · Celltrion
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for CT-P6, covering 2016-08-26 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: To Compare the Pharmacokinetics, Safety, and Immunogenicity of Subcutaneous CT-P6 and Herceptin in Healthy Male Subjects (Trastuzumab) [Phase 1]

See pricing